Femoral Nerve Mobilization for Patients With Knee Osteoarthritis
RCT
Effects of Femoral Nerve Mobilization on Pain Intensity, Function, Quality of Life and Central Sensitization in Patients With Knee Osteoarthritis
1 other identifier
interventional
50
1 country
1
Brief Summary
Background: Knee osteoarthritis (KO) is considered as a cause of disability among the elderly, causing pain, reduced quality of life, and decreased functionality. There is a limited knowledge about using femoral nerve mobilization in treating patients with arthritic changes. Objectives: This study will be designed to determine the efficacy of adding of femoral nerve mobilization on pain intensity, function, quality of life and central sensitization in patients with knee osteoarthritis Methods: Thirty patients (aged ≥50 years with KO Kellgren-Lawrence grades I-II) will be included in this study: Patients will randomly be assigned into two groups: group A will receive traditional physical therapy while group B will receive femoral nerve mobilization in addition to traditional physical therapy. Three sessions will be performed for four weeks by 3 session /week. Patients will be evaluated for pain intensity using the numerical rating scale (NRS), knee function by WOMAC scale, quality of life by 12-item Short Form Survey questionnaire (SF-12) and central sensitization by the Arabic version of central sensitization inventory (CSI).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 15, 2025
CompletedStudy Start
First participant enrolled
December 20, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2026
CompletedJanuary 9, 2026
December 1, 2025
2 months
December 15, 2025
December 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
pain intensity
The pain was assessed by the numerical rating scale (NRS) where zero indicating no pain and 10 indicating maximal pain
after 4 weeks
central sensitization
The CSI is a validated questionnaire designed to identify symptoms associated with central sensitization. It has two components: Scale A assesses 25 common symptoms in individuals with central sensitization, resulting in a score ranging from 0 to 100. This score was interpreted as follows: subclinical (0-29), mild (30-39), moderate (40-49), severe (50-59), and extreme (60-100). Scale B, which is not scored, collects information on previous diagnoses of specific diseases
after 4 weeks
Study Arms (2)
Control group
ACTIVE COMPARATORTraditional physical therapy
Neural mobilization group
EXPERIMENTALtraditional physical therapy plus femoral nerve mobilization
Interventions
stretching exercises for hamstring, calf muscles and iliotibial band in addition to isotonic exercise for hip extensors and abductors and isometric quadriceps exercise
A physiotherapist guided the patients in performing active mobilization of the femoral nerve. The prescribed method for active neural mobilization involved assuming a prone position supported by the forearms with a slight extension of the spine, flexion of the knee, and extension of the cervical spine. This was followed by performing the opposite movement
Eligibility Criteria
You may qualify if:
- patients aged 50 years or older, diagnosed with KO according to theAmerican College of Rheumatology's criteria with knee pain, and grade I or II on the Kellgren-Lawrence radiographic scale
You may not qualify if:
- individuals suffering from chronic conditions considered to be perpetuating factors (e.g., fibromyalgia)
- those with conditions causing lower extremity pain
- individuals who had taken analgesics within 24 h before evaluations
- those who had undergone corticosteroid or local anesthetic infiltration in the year prior to the study or during the follow-up period
- those using substances that could interfere with treatment
- those with a previous diagnosis of neuropathy (lumbosacral plexus) or myopathy
- those with contraindications to mobilization or exercise, and those with cognitive deficits (dementia, Alzheimer's).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince Sattam bin Abdulaziz University
Al Kharj, 16242, Saudi Arabia
Related Publications (3)
Pedersini P, Valdes K, Cantero-Tellez R, Cleland JA, Bishop MD, Villafane JH. Effects of Neurodynamic Mobilizations on Pain Hypersensitivity in Patients With Hand Osteoarthritis Compared to Robotic Assisted Mobilization: A Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2021 Feb;73(2):232-239. doi: 10.1002/acr.24103. Epub 2021 Jan 3.
PMID: 31675184RESULTSerrano-Garcia B, Martinez-Cepa CB, Forriol F, Zuil-Escobar JC. Active Neurodynamic Technique at Home in Patients with Knee Osteoarthritis: An Open Single Arm Clinical Trial. Medicina (Kaunas). 2024 Nov 12;60(11):1857. doi: 10.3390/medicina60111857.
PMID: 39597042RESULTSerrano-Garcia B, Forriol-Campos F, Zuil-Escobar JC. Active Neurodynamics at Home in Patients with Knee Osteoarthritis: A Feasibility Study. J Clin Med. 2023 Oct 20;12(20):6635. doi: 10.3390/jcm12206635.
PMID: 37892772RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assisstant professor , department of health and rehabilitation sciences, college of applied medical siences
Study Record Dates
First Submitted
December 15, 2025
First Posted
January 9, 2026
Study Start
December 20, 2025
Primary Completion
February 10, 2026
Study Completion
February 25, 2026
Last Updated
January 9, 2026
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share